Wesana Health(OTC) WSNAF

Current Price$0.00

Market Cap$73.20K

Since IPO (2021)-100%

5 Year-100%

1 Year-89%

1 Month+0%

Wesana Health last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-14

Wesana Health stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-04-21
1 month	+0%	USD 0.00	2026-04-21
3 month	+349,900%	USD 0.00	2026-04-02
Year to date	-65%	USD 0.01	2025-12-31
1 year	-89.49%	USD 0.03	2025-07-14
3 year	-92.22%	USD 0.05	2023-07-14
5 year	-99.83%	USD 2.10	2021-07-15
Since inception	-99.89%	USD 3.10	2021-05-10

Wesana Health Financials at a Glance

Market Cap

$73.20K

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.18M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-747.99 (Low)

Dividend

$0.00

Beta (Volatility)

-747.99 (Low)

Price

$0.00

Volume

1,200

Open

$0.00

Price

$0.00

Volume

1,200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.06

Estimated Earnings Date

Aug 28, 2026

Dividend

$0.00

Beta (Volatility)

-747.99 (Low)

Price

$0.00

Volume

1,200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.06

Estimated Earnings Date

Aug 28, 2026

WSNAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Wesana Health

Wesana Health Holdings Inc. is a life sciences company focused on developing psychedelic-based therapies, particularly psilocybin-enhanced psychotherapy, aimed at treating traumatic brain injuries (TBI). The firm is dedicated to creating scientifically validated compounds and therapeutic strategies to help patients recover from trauma-related neurological and mental health conditions.

Products and Services

Psilocybin-enhanced psychotherapy for TBI treatment
Research and development of psychedelic compounds
Therapeutic strategies for mental health recovery

Growth Outlook

Significant market potential in the psychedelic therapy sector
Increasing acceptance of psychedelic treatments in healthcare
Focus on innovative research to expand therapeutic applications

Financial Highlights

Recent quarterly net income of -$36,666, showing ongoing investment in R&D
Trailing twelve months (TTM) revenue of $0, indicating early-stage development
Cash and short-term investments of $46,929 as of Q3 2024

Wesana Health Holdings Inc. operates in a rapidly evolving biotechnology sector, with a mission to address significant unmet needs in mental health treatment. The company's focus on psychedelic therapies positions it at the forefront of a growing market, driven by increasing recognition of the potential benefits of these treatments. Despite current financial challenges, including a net loss in recent quarters, the commitment to research and development suggests a long-term vision aimed at establishing a strong foothold in the industry. The company's cash reserves provide a foundation for continued operations and exploration of innovative therapeutic solutions.

AI Generated • Jul 21, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Daniel Carcillo

Website

www.wesanahealth.com

Headquarters

Chicago, IL 60607, US

WSNAF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-506.80%

Return on Capital

N/A

Return on Assets

-176.71%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$73.20K

Shares Outstanding

20.92M

Volume

1.20K

Avg. Volume

19.355

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$460.16K

EBITDA

-$567.22K

Operating Cash Flow

-$422.96K

Capital Expenditure

$1.00

Free Cash Flow

-$422.95K

Cash & ST Invst.

$46.93K

Total Debt

$250.00K

Wesana Health Performance Analysis

Wesana Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 0	N/A
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A

Wesana Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2023-12-31	N/A
Q1	2024-03-31	N/A
Q2	2024-06-30	N/A
Q3	2024-09-30	N/A

Wesana Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -1.48	N/A
2022	2022-12-31	USD -0.25	-83.1%
2023	2023-12-31	USD -0.05	-80.3%

Wesana Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2023-12-31	-300.0%
Q1	2024-03-31	82.8%
Q2	2024-06-30	8.2%
Q3	2024-09-30	82.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$73.20K

N/A

Market Cap/Employee

$10.46K

N/A

Employees

N/A

Net Income

-$36.67K

-105.9%

EBITDA

-$33.06K

+96.4%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Total Cash

$46.93K

-93.1%

Total Debt

$250.00K

+0.0%

Accounts Receivable

$50.92K

-94.6%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$250.00K

+0.0%

Return on Assets

-1.77%

N/A

Return on Invested Capital

4.13%

N/A

Free Cash Flow

-$16.68K

+93.2%

Operating Cash Flow

-$16.68K

+93.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LFCOFLift & Co. Corp.

LFCOFLift & Co. Corp.$0.00+0.00%

NBIONascent Biotech, Inc.

NBIONascent Biotech, Inc.$0.00+0.00%

RGBPRegen BioPharma, Inc.

RGBPRegen BioPharma, Inc.$0.00+7.14%

RGRXRegeneRx Biopharmaceuticals, Inc.

RGRXRegeneRx Biopharmaceuticals, Inc.$0.00+0.00%

GRVEGroove Botanicals, Inc.

GRVEGroove Botanicals, Inc.$0.00+0.00%

RASPActavia Life Sciences, Inc.

RASPActavia Life Sciences, Inc.$0.00+0.00%

IPIXInnovation Pharmaceuticals Inc.

IPIXInnovation Pharmaceuticals Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$92.32-0.08%

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

Questions About WSNAF

What is the current price of Wesana Health?

Wesana Health is trading at $0.00 per share.

What is the 52-week range for Wesana Health?

Over the past 52 weeks, Wesana Health has traded between $0.00 and $0.06.

How much debt does Wesana Health have?

As of the most recent reporting period, Wesana Health reported total debt of $250.00K.

How much cash does Wesana Health have on hand?

Wesana Health reported $44.30K in cash and cash equivalents in its most recent financial results.

What is Wesana Health’s dividend yield?

Wesana Health does not currently have a dividend yield.

Wesana Health(OTC) WSNAF

Wesana Health Financials at a Glance

WSNAF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Wesana Health

WSNAF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Wesana Health Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WSNAF

What is the current price of Wesana Health?

What is the 52-week range for Wesana Health?

How much debt does Wesana Health have?

How much cash does Wesana Health have on hand?

What is Wesana Health’s dividend yield?

Premium Investing Services